
    
      To participate in this study, patients must have disease that can be measured on a CT scan.
      Brain metastases are OK if stable. Pregnant and/or nursing women may not participate. This
      drug has been approved by the FDA for the treatment of advanced renal cell cancer and a
      certain type of stomach/intestinal cancer. Its efficacy in lung cancer in currently unknown.
      Common side effects include fatigue, nausea, diarrhea, skin reaction, and decreased blood
      counts.
    
  